This video takes a closer look at three top blue chip companies which may be in focus for investors this earnings season. After all, with recent risks to the market, investors have been focusing more on blue chips and large caps in general, potentially ...
AZN stock was down $7.28, or 9.07%, in pre-market trading. YTD, the stock is up 37.07%. PFE stock was up 38 cents, or 1.3%, in pre-market trading. YTD, the stock is down 4.4%. Shares of AstraZeneca (AZN) offer a dividend yield of 3.49% based on Friday’s ...
Investors who purchased a significant amount of shares of Pfizer Inc (NYSE:PFE) between October 31 ... investors who purchased or otherwise acquired the publicly-traded common stock of Pfizer Inc between November 1, 2000 and November 10, 2004, against ...
SBWire · 1y
ICU Medical Inc : ICU Medical Inc to acquire the Hospira Infusion Systems business from Pfizer Inc for $1 billion in cash and stock . Deal for $1 billion . Pfizer will receive approximately $400 million in newly issued shares of ICU Medical common stock
Reuters · 1y
GILD closed Monday's trading at $80.92, down 0.10%. Pfizer Inc. (PFE) is all set to acquire Medivation Inc. (MDVN) for $81.50 a share in cash for a total enterprise value of approximately $14 billion. The merger is expected to be immediately accretive to ...
RTTNews · 1y
U.S. stock futures traded lower in early pre-market trade. The Chicago Fed National Activity Index for July is schedule for release at 8:30 a.m. ET. Futures for the Dow Jones Industrial Average fell 51 points to 18,489.00, while the Standard & Poor’s 500 ...
(NYSE: AGN) announced the largest healthcare deal in history today (Monday). But despite the historic news, the PFE stock price was down 2.3% today. Allergan stock was down 3%. In a record-breaking $160 billion merger, the Pfizer-Allergan combination will ...
Tara Clarke: Pfizer Inc. (NYSE:PFE) will soon feel the pressure from the wave of lawsuits being filed claiming that Pfizer’s blockbuster drug Lipitor – the world’s best-selling drug of all time – causes type-2 diabetes in women. With a market ...
Two American pharmaceutical giants reported earnings this morning, both showing flagging sales – but one ended the day with a gain. Merck & Co. Inc. (NYSE: MRK) shares gained 1.05% to close at $58.58 while Pfizer Inc. (NYSE: PFE) stock fell 1.23% to $29.73.